Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis-a binational multicenter

Luregn J Schlapbach1,2,3, Roberto Chiletti4,5, Lahn Straney6,7

  • 1Paediatric Critical Care Research Group, Child Health Research Centre, The University of Queensland, Brisbane, Australia. l.schlapbach@uq.edu.au.

Insights

Extracorporeal membrane oxygenation (ECMO) may benefit pediatric septic shock patients if their predicted mortality risk exceeds 47.1%. Central cannulation improved survival on ECMO, suggesting a randomized trial is not feasible.

Area of Science:

  • Pediatric Critical Care Medicine
  • Cardiopulmonary Support
  • Septic Shock Management

Background:

  • The Surviving Sepsis Campaign suggests extracorporeal membrane oxygenation (ECMO) for refractory septic shock.
  • Defining the benefit threshold for ECMO in pediatric septic shock is crucial.

Purpose of the Study:

  • To establish benefit thresholds for ECMO in pediatric septic shock.
  • To identify predictors of survival in children treated with ECMO.

Main Methods:

  • Retrospective binational multicenter cohort study (2002-2016) of pediatric patients (<16 years) with sepsis and septic shock.
  • Developed sepsis-specific risk-adjusted models to determine ECMO benefit thresholds using early clinical variables.
  • Performed multivariate analyses to identify survival predictors in ECMO-treated children.

Main Results:

  • A model using 12 variables predicted mortality with high accuracy (AUROC 0.879).
  • The benefit threshold was a 47.1% predicted mortality risk.
  • Observed mortality was lower than predicted for patients above this threshold (SMR 0.61).
  • Lower lactate, no prior cardiac arrest, and central cannulation predicted survival on ECMO.

Conclusions:

  • A predictive model can define ECMO benefit thresholds in pediatric septic shock.
  • Central cannulation is associated with improved survival on ECMO.
  • A large randomized controlled trial on ECMO for sepsis is likely not feasible.
Abstract